ערך בספרים למניה: coyatherapeutics.com (COYA)

The prospects for Coya Therapeutics, Inc. (COYA) are based on the commercialization of T-cell therapies for Parkinson's and Alzheimer's diseases. Fluctuations in the book value per share clearly demonstrate the dynamics of net assets, with the indicator currently standing at 1.83. Business stability is supported by the humanitarian status of developments in the US, while the high scalability of intellectual property ensures the global implementation of products with minimal costs.

Book value separates real net assets from speculative expectations, recording the actual amount of capital per share without subjective valuations. By analyzing the historical book value chart, an investor can see the foundation of Coya Therapeutics, Inc. (COYA), where high scalability of intellectual property allows for the expansion of a global presence with low production costs, confirming the business's resilience to stagnation.